Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CervoMed Inc. (CRVO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CervoMed Inc. (CRVO), most recent 12 months reported: revenue $331.3K, net loss $30.35M. Latest balance sheet on file: liquid cash $24.94M. From SEC filings. Others in Pharmaceutical Preparations: Quantum Cyber N.V. · MEREO BIOPHARMA GROUP PLC · Can-Fite BioPharma Ltd. · PROVECTUS BIOPHARMACEUTICALS, INC. · Allarity Therapeutics, Inc. · REGEN BIOPHARMA, INC. · Clene Inc. · LEXARIA BIOSCIENCE CORP.

Stock screener

Watchlist